Zipnosis certified by Surescripts to add medication history to virtual care platform

Zipnosis, providers of virtual care software, has been certified by Surescripts to add medication history services to its virtual care platform.

The certification allows providers to view real-time medication history validation and prescriptions from the updated provider workflow. Additionally, Zipnosis will provide extra safety features including medication interaction and allergy checking as well as prescribing precautions related to pregnancy and breastfeeding. The added functions to the platform allow providers to make more accurate decisions on medications using personalized healthcare data.

"Ensuring the safety and efficacy of care delivered through the Zipnosis platform continues to be our highest priority," said Kevin Smith, MD, chief medical information officer at Zipnosis. "Incorporating Surescripts medication history information as part of the provider workflow further enhances their ability to make clinically sound prescribing decisions and streamlines their experience with the platform."

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.